Oncology Biosimilar Market: Information By Types Of Cancer, Drug Type, Distribution Channel and Regional Outlook — Global Insights Forecast Till 2026

Apr 04, 2019   Global Statistics Representing Oncology Biosimilar Market Scenario Oncology Biosimilar is the identical copy of oncology biologics used for the treatment of cancer. These drugs are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. According to the World Health Organization (WHO), in 2015, approximately 8.8 million people died due to cancer worldwide. Increasing pr...
Request Free Sample Report
TABLE OF CONTENT

Table Of Content

TABLE OF CONTENTS

1              Introduction

1.1          Market Definition

1.2          Market Scope

2              Research Methodology

2.1          Primary Research

2.2          Research Methodology

2.3          Assumptions & Exclusions

2.4          Secondary Data Sources

3              Market Overview

3.1          Report Segmentation & Scope

3.2          Value Chain Analysis: Oncology Biosimilar Market

3.3          Key Market Trends

3.3.1      Drivers

3.3.2      Restraints

3.3.3      Opportunities

3.4          Porter’s Five Forces Analysis

3.4.1      Bargaining Power of Suppliers

3.4.2      Bargaining Power of Buyers

3.4.3      Threat of Substitution

3.4.4      Threat of New Entrants

3.4.5      Competitive Rivalry

3.5          Market Share Analysis

4              By Types of Cancer

4.1          Introduction

4.1.1      Market Size & Forecast (Value)

4.2       Breast Cancer

4.3       Colorectal Cancer

4.4       Blood Cancer

4.5       Neutropenia Cancer

       4.6       Non-Small Cell Lung Cancer

5              By Drug Type

5.1          Introduction

5.1.1      Market Size & Forecast (Value)

5.2      mAb

5.3      Immunomodulators

5.4      Hematopoietic agents

5.5      G-CSF

5.6      Others

6              Regional Overview

6.1          Introduction

6.1.1      Market Size & Forecast (Value)

6.2          America

6.2.1      North America

6.2.1.1   U.S.

6.2.1.1.1               By Types of Cancer

6.2.1.1.2              By Drug Type  

6.2.1.2   Canada

6.2.1.2.1               By Types of Cancer

6.2.1.2.2               By Drug Type  

6.2.1.3   Mexico

6.2.1.3.1               By Types of Cancer

6.2.1.1.2              By Drug Type  

6.2.2      Latin America

6.2.2.1                   By Types of Cancer

6.2.2.2                  By Drug Type  

6.3          Europe

6.3.1      Market Size & Forecast (Value)

6.3.2      Germany

6.3.2.1                   By Types of Cancer

6.3.2.2                 By Drug Type  

6.3.3      France

6.3.3.1                   By Types of Cancer

6.3.3.2                   By Drug Type  

6.3.4      U.K.

6.3.4.1                   By Types of Cancer

6.3.4.2                   By Drug Type  

6.3.5      Italy

6.3.5.1                   By Types of Cancer

6.3.5.2                   By Drug Type  

6.3.6      Spain

6.3.6.1                   By Types of Cancer

6.3.6.2                   By Drug Type  

6.3.7      Rest of Europe

6.3.7.1                   By Types of Cancer

6.3.7.2                  By Drug Type  

6.4          Asia Pacific

6.4.1      Market Size & Forecast (Value)

6.4.2      Japan

6.4.2.1                   By Types of Cancer

6.4.2.2                 By Drug Type  

6.4.3      China

6.4.3.1                   By Types of Cancer

6.4.3.2                  By Drug Type  

6.4.4      Australia

6.4.4.1                   By Types of Cancer

6.4.4.2                   By Drug Type  

6.4.5      India

6.4.5.1                   By Types of Cancer

6.4.5.2                 By Drug Type  

6.4.6      South Korea

6.4.6.1                   By Types of Cancer

6.4.6.2                 By Drug Type  

6.4.7      Rest of Asia-Pacific

6.4.7.1                   By Types of Cancer

6.4.7.2                   By Drug Type  

6.5          Middle East & Africa

6.5.1      Market Size & Forecast (Value)

6.5.2      Saudi Arabia

6.5.2.1                   By Types of Cancer

6.5.2.2                   By Drug Type  

6.5.3      South Africa

6.5.3.1                   By Types of Cancer

6.5.3.2                 By Drug Type  

6.5.4      Kuwait

6.5.4.1                   By Types of Cancer

6.5.4.2                 By Drug Type  

6.5.5      Rest of Middle East & Africa

6.5.5.1                   By Types of Cancer

6.5.5.2                 By Drug Type  

7.            Company Profile

7.1          Teva Pharmaceutical Industries Ltd.

7.1.1      Company Overview

7.1.2      Financial Performance

7.1.3      Recent Developments

7.1.4      Product Portfolio

7.2          Biocon

7.2.1      Company Overview

7.2.2      Financial Performance

7.2.3      Recent Developments

7.2.4      Product Portfolio

7.3          STADA Arzneimittel AG

7.3.1      Company Overview

7.3.2      Financial Performance

7.3.3      Recent Developments

7.3.4      Product Portfolio

7.4          Sandoz International GmbH

7.4.1      Company Overview

7.4.2      Financial Performance

7.4.3      Recent Developments

7.4.4      Product Portfolio

7.5          Intas Pharmaceuticals Ltd.

7.5.1      Company Overview

7.5.2      Financial Performance

7.5.3      Recent Developments

7.5.4      Product Portfolio

7.6          Celltrion Inc.

7.6.1      Company Overview

7.6.2      Financial Performance

7.6.3      Recent Developments

7.6.4      Product Portfolio

7.7          Pfizer Inc.

7.7.1      Company Overview

7.7.2      Financial Performance

7.7.3      Recent Developments

7.7.4      Product Portfolio

7.8          Apotex Inc.

7.8.1      Company Overview

7.8.2      Financial Performance

7.8.3      Recent Developments

7.8.4      Product Portfolio

7.9          Dr. Reddy’s Laboratories Ltd.

8.9.1      Company Overview

7.9.2      Financial Performance

7.9.3      Recent Developments

7.9.4      Product Portfolio

7.10        BIOCAD

7.10.1    Company Overview

7.10.2    Financial Performance

7.10.3    Recent Developments

7.10.4    Product Portfolio